TUCSON, AZ (Tucson News Now) - Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level. The recalled product has been found to potentially have higher concentrations of ibuprofen. The company is warning that there is a possibility that infants may be more vulnerable to permanent NSAID-associated kidney injury because they are more susceptible to a higher potency level of the drug. Side effects are nausea, vomiting, epigastric pain, or more rarely, diarrhea. Tinnitus, headache and gastrointestinal bleeding are also possible adverse effects. To...